Miss Maria Ann Mignone, M.S. CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 404 E Main St, Upstairs Apt., Granville, IL 61326 Phone: 815-579-8740 |
News Archive
Lack of adequate sleep can lead to increased injuries among preschool children, new research shows.
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
In the evolving global healthcare marketplace, a patient-centric approach has become part of the formula for long-term success in the pharmaceutical sector. Facing declining sales from patent losses and payer pressures, the pharma sector is turning to patient support programs and activities to help drive clinical and commercial success.
Researchers at Mount Sinai School of Medicine have identified a new drug target that may treat and/or prevent heart failure. The team evaluated failing human and pig hearts and discovered that SUMO1, a so-called "chaperone" protein that regulates the activity of key transporter genes, was decreased in failing hearts.
› Verified 8 days ago